0
0

PILLS Act

12/19/2024, 9:07 AM

Summary of Bill HR 6109

Bill 118 hr 6109, also known as the PILLS Act, is a piece of legislation currently being considered by the US Congress. The primary goal of this bill is to address the opioid crisis that has been plaguing the country in recent years.

The PILLS Act aims to improve the monitoring and regulation of prescription drugs, particularly opioids, in order to prevent abuse and addiction. One of the key provisions of the bill is the establishment of a national prescription drug monitoring program, which would track the prescribing and dispensing of controlled substances across state lines.

Additionally, the PILLS Act would require healthcare providers to undergo training on proper prescribing practices for opioids, as well as implement stricter guidelines for the disposal of unused medications. The bill also includes provisions for increasing access to addiction treatment services for individuals struggling with opioid addiction. Overall, the PILLS Act is a comprehensive piece of legislation that seeks to address the opioid crisis from multiple angles, including prevention, treatment, and regulation. If passed, this bill has the potential to make a significant impact in combating the devastating effects of opioid abuse in the United States.

Current Status of Bill HR 6109

Bill HR 6109 is currently in the status of Bill Introduced since October 26, 2023. Bill HR 6109 was introduced during Congress 118 and was introduced to the House on October 26, 2023.  Bill HR 6109's most recent activity was Referred to the Subcommittee on Health. as of December 17, 2024

Bipartisan Support of Bill HR 6109

Total Number of Sponsors
2
Democrat Sponsors
0
Republican Sponsors
2
Unaffiliated Sponsors
0
Total Number of Cosponsors
4
Democrat Cosponsors
0
Republican Cosponsors
4
Unaffiliated Cosponsors
0

Policy Area and Potential Impact of Bill HR 6109

Primary Policy Focus

Taxation

Alternate Title(s) of Bill HR 6109

PILLS Act
PILLS Act
Producing Incentives for Long-term production of Lifesaving Supply of Medicine Act
To amend the Internal Revenue Code of 1986 to establish the generic drugs and biosimilars production credit, and for other purposes.

Comments